People news

Share this article:
Otsuka American Pharmaceutical, Inc. (OAPI) has announced the appointment of Mark Altmeyer to president and CEO. Altmeyer succeeds interim president and CEO Dean Haubrich, who has lead the company since Aug. 1, 2008. Haubrich has been named chairman of the OAPI's board. Altmeyer was most recently SVP, global commercialization for oncology at Bristol-Myers Squibb. 
Cambridge, Massachusetts-based Genocea Biosciences, a vaccine discovery and development company, announced the hiring of Jane Halpern as vice president, regulatory affairs. Halpern was most recently director of regulatory affairs and head of technical regulatory affairs, North America, for GlaxoSmithKline Biologicals.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media